Sverre Lehmann

Associate Professor

Department of Clinical Science

Show CV

E-mailsverre.lehmann@uib.no
Phone+47 971 97 288
Visitor Address
Haukeland universitetssykehus, Laboratoriebygget

5009 Bergen
Postal Address
Postboks 7804

5020 Bergen

Publications

Academic article

Show author(s) (2024). Lower airway microbiota in COPD and healthy controls. Thorax.

Show author(s) (2023). Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort. European Respiratory Journal Open Research (ERJ Open Research).
Show author(s) (2023). Prevalence and impact of exercise-induced laryngeal obstruction in asthma: a study protocol for a cross-sectional and longitudinal study. BMJ Open. 8 pages.
Show author(s) (2023). Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry. Journal of Allergy and Clinical Immunology: In Practice. 2732-2747.
Show author(s) (2023). General and orofacial symptoms associated with acute and long COVID in 80- and 90-year-old Swedish COVID-19 survivors. Journal of Dentistry.
Show author(s) (2023). Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both. Allergy. European Journal of Allergy and Clinical Immunology. 1934-1948.

Show author(s) (2022). The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis. Microbiome. 11 pages.
Show author(s) (2022). The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease . PLOS ONE.
Show author(s) (2022). Clinical information predicting severe obstructive sleep apnea: A cross-sectional study of patients waiting for sleep diagnostics. Respiratory Medicine.
Show author(s) (2022). Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy. Journal of Asthma and Allergy. 1491-1510.
Show author(s) (2022). Characteristics of hypertension and arterial stiffness in obstructive sleep apnea: A Scandinavian experience from a prospective study of 6408 normotensive and hypertensive patients. The Journal of Clinical Hypertension. 385-394.
Show author(s) (2022). Association of Excessive Sleepiness, Pathological Fatigue, Depression, and Anxiety With Different Severity Levels of Obstructive Sleep Apnea. Frontiers in Psychology. 1-8.

Show author(s) (2021). Partner perceptions are associated with objective sensor-measured adherence to oral appliance therapy in obstructive sleep apnea. Journal of Sleep Research.
Show author(s) (2021). Inducible laryngeal obstruction in asthma. European Respiratory Journal.
Show author(s) (2021). Effect of Continuous Positive Airway Pressure on Symptoms and Prevalence of Insomnia in Patients With Obstructive Sleep Apnea: A Longitudinal Study. Frontiers in Psychology. 10 pages.

Show author(s) (2020). NORDSTAR: paving the way for a new era in asthma research. European Respiratory Journal. 7 pages.
Show author(s) (2020). Effect of continuous positive airway pressure on symptoms of anxiety and depression in patients with obstructive sleep apnea. Sleep and Breathing. 1-7.
Show author(s) (2020). Complications and discomfort after research bronchoscopy in the MicroCOPD study. BMJ Open Respiratory Research.
Show author(s) (2020). Acoustic pharyngometry - A new method to facilitate oral appliance therapy. Journal of Oral Rehabilitation. 1-13.

Show author(s) (2019). Motivation and response rates in bronchoscopy studies. Multidisciplinary Respiratory Medicine. 1-9.
Show author(s) (2019). Health-related quality of life as predictor for mortality in patients treated with long-term mechanical ventilation. BMC Pulmonary Medicine. 1-12.
Show author(s) (2019). A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: The DuoSleep study. The International Journal of Chronic Obstructive Pulmonary Disease. 199-210.

Show author(s) (2018). Prevalence of several somatic diseases depends on the presence and severity of obstructive sleep apnea. PLOS ONE. 1-12.
Show author(s) (2018). Prevalence of parasomnias in patients with obstructive sleep apnea. A registry-based cross-sectional study. Frontiers in Psychology. 1-7.
Show author(s) (2018). No effect of a self-help book for insomnia in patients with obstructive sleep apnea and comorbid chronic insomnia – a randomized controlled trial. Frontiers in Psychology. 2413.
Show author(s) (2018). Increased severity of obstructive sleep apnea is associated with less anxiety and depression. Journal of Sleep Research.
Show author(s) (2018). Akustisk pharyngometri for bedre resultat av behandling med søvnapnéskinner. Den norske tannlegeforenings tidende. 264-267.

Show author(s) (2017). Reliability of an adherence monitoring sensor embedded in an oral appliance used for treatment of obstructive sleep apnea. Journal of Oral Rehabilitation. 110-115.
Show author(s) (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
Show author(s) (2017). Oral appliance treatment outcome can be predicted by continuous positive airway pressure in moderate to severe obstructive sleep apnea. Sleep and Breathing. 1-8.
Show author(s) (2017). Lungefunksjon som risikofaktor for osteoporose og hoftebrudd. Best Practice.
Show author(s) (2017). Factors associated with change in health-related quality of life among individuals treated with long-term mechanical ventilation, a 6-year follow-up study. Journal of Advanced Nursing. 651-665.
Show author(s) (2017). A pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability. BMC Research Notes.

Show author(s) (2016). The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function. BMC Research Notes. 8 pages.
Show author(s) (2016). Oral appliance treatment in moderate and severe obstructive sleep apnoea patients non-adherent to CPAP. Journal of Oral Rehabilitation. 249-258.
Show author(s) (2016). Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population. Clinical Respiratory Journal. 31-39.
Show author(s) (2016). Airflow limitation as a risk factor for low bone mineral density and hip fracture. The Hordaland Health Study (HUSK) – 10 years follow-up of a general population. European Clinical Respiratory Journal. 8 pages.
Show author(s) (2016). Airflow limitation as a risk factor for low bone mineral density and hip fracture. European Clinical Respiratory Journal.

Show author(s) (2015). The Norwegian version of the Severe Respiratory Insufficiency Questionnaire. International Journal of Nursing Practice. 229-238.
Show author(s) (2015). Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. Journal of Internal Medicine. 59-67.
Show author(s) (2015). Prevalence of excessive sleepiness is higher whereas insomnia is lower with greater severity of obstructive sleep apnea. Sleep and Breathing. 1387-1393.

Show author(s) (2014). Prevalence and correlates of insomnia and excessive sleepiness in adults with obstructive sleep apnea symptoms. Perceptual and Motor Skills. 571-586.

Show author(s) (2013). Electronic optional guidelines as a tool to improve the process of referring patients to specialized care: An intervention study. Scandinavian Journal of Primary Health Care. 166-171.

Show author(s) (2011). En kvinne med tilbakevendende arteriovenøse tromboser. Tidsskrift for Den norske legeforening. 1303-1306.

Show author(s) (2010). Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clinical Respiratory Journal. 13-21.

Show author(s) (2008). Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. Clinical Respiratory Journal. 10-25.
Show author(s) (2008). Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 205-213.

Show author(s) (2007). Bronchodilator response to adrenergic (beta) (2)-agonists: Relationship to symptoms in an adult community. Respiratory Medicine. 1183-1190.

Show author(s) (2006). Post-bronchodilator spirometry reference values in adults and implications for disease management. American Journal of Respiratory and Critical Care Medicine. 1316-1325.
Show author(s) (2006). Nordic physician's management of asthma and chronic obstructive pulmonary disease. Respiratory Medicine. S31-S37.
Show author(s) (2006). Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta(2)-agonist. Pulmonary Pharmacology & Therapeutics. 272-280.

Show author(s) (2004). Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly. Respiratory Medicine. 1071-1079.

Lecture

Show author(s) (2014). Søvnforstyrrelser.

Academic lecture

Show author(s) (2014). Effect Of Rosuvastatin Treatment In Stable COPD (RODEO) .

Reader opinion piece

Show author(s) (2014). Oral appliance for sleep apnea. Tidsskrift for Den norske legeforening. 1030-1031.

Show author(s) (2007). Defining the lower limit of normal for FEV1/FVC - From the authors. American Journal of Respiratory and Critical Care Medicine. 101-102.

Show author(s) (2005). Behandling av obstruktiv søvnapné. Tidsskrift for Den norske legeforening. 199.